Abstract:Background Alternol is a natural compound isolated from fermentation products of a mutant fungus. Our previous studies demonstrated that Alternol specifically kills cancer cells but spares benign cells. Methods To investigate the mechanism underlying alternol‐induced cancer cell‐specific killing effect, we took a comprehensive strategy to identify Alternol's protein targets in prostate cancer cells, including PC‐3, C4‐2, and 22RV1, plus benign BPH1 cell lines. Major experimental techniques included biotin‐streptavidin pulldown assay coupled with mass‐spectrometry, in vitro enzyme activity assay for Krebs cycle enzymes and gas chromatography‐mass spectrometry (GC‐MS) for metabolomic analysis. Results Among 14 verified protein targets, four were Krebs cycle enzymes, fumarate hydratase (FH), malate dehydrogenase‐2 (MDH2), dihydrolipoamide acetyltransferase (DLAT) in pyruvate dehydrogenase complex (PDHC) and dihydrolipoamide S‐succinyltransferase (DLST) in a‐ketoglutarate dehydrogenase complex (KGDHC). Functional assays revealed that PDHC and KGDHC activities at the basal level were significantly higher in prostate cancer cells compared to benign prostate BPH1 cells, while alternol treatment reduced their activities in cancer cells close to the levels in BPH1 cells. Although FH and MDH2 activities were comparable among prostate cancer and benign cell lines at the basal level, Alternol treatment largely increased their activities in cancer cells. Metabolomic analysis revealed that Alternol treatment remarkably reduced the levels of malic acid, fumaric acid, and isocitric acid and mitochondrial respiration in prostate cancer cells. Alternol also drastically reduced mitochondrial respiration and ATP production in PC‐3 cells in vitro or in xenograft tissues but not in BPH1 cells or host liver tissues. Conclusions Alternol interacts with multiple Krebs cycle enzymes, resulting in reduced mitochondrial respiration and ATP production in prostate cancer cells and xenograft tissues, providing a novel therapeutic strategy for prostate cancer treatment.

Natural compound Alternol exerts a broad anti-cancer spectrum and a superior therapeutic safety index in vivo

Alternol Exerts Prostate‐selective Antitumor Effects Through Modulations of the AMPK Signaling Pathway

Alternol Eliminates Excessive ATP Production by Disturbing Krebs Cycle in Prostate Cancer.

Alternol, a Natural Compound, Exerts an Anti‐tumour Effect on Osteosarcoma by Modulating of STAT3 and ROS/MAPK Signalling Pathways

Cell Growth Inhibition, G2M Cell Cycle Arrest, and Apoptosis Induced by the Novel Compound Alternol in Human Gastric Carcinoma Cell Line MGC803.

Alternol inhibits the proliferation and induces the differentiation of the mouse melanoma B16F0 cell line

Alternol Triggers Immunogenic Cell Death Via Reactive Oxygen Species Generation

Alternol Sensitizes Renal Carcinoma Cells to TRAIL-Induced Apoptosis

Growth Inhibition and Apoptosis Induction by Alternol in Pancreatic Carcinoma Cells.

Natural compound Alternol actives multiple endoplasmic reticulum stress-responding pathways contributing to cell death

In Vitro Anticancer Effects of Two Novel Phenanthroindolizidine Alkaloid Compounds on Human Colon and Liver Cancer Cells.

Alteronol Enhances the Anti-tumor Activity and Reduces the Toxicity of High-Dose Adriamycin in Breast Cancer

General toxicity and genotoxicity of alternariol: a novel 28-day multi-endpoint assessment in male Sprague–Dawley rats

Alternol inhibits migration and invasion of human hepatocellular carcinoma cells by targeting epithelial-to-mesenchymal transition

Inhibitory Effects of Natural Compound Alantolactone on Human Non-small Cell Lung Cancer A549 Cells

Potent Inhibition of Gastric Cancer Cells by a Natural Compound Via Inhibiting TrxR1 Activity and Activating ROS-mediated P38 MAPK Pathway

In Vitro Anti-Cancer Activity Of A Novel Microbial Fermentation Product On Human Carcinomas

Preclinical Toxicology and Toxicokinetic Evaluation of Ailanthone, a Natural Product Against Castration-Resistant Prostate Cancer, in Mice.

In‐silico and In‐vitro Investigation of Flavonoids and Alkaloids from Artocarpus heterophyllus, Tinospora cordifolia, and Glycosmis pentaphylla as Potential NF‐κB Inhibitors in Oral Cancer

Isolation, Structure Elucidation, and Mutagenicity of Four Alternariol Derivatives Produced by the Mangrove Endophytic Fungus No. 2240

Novel Non-Trimethoxylphenyl Piperlongumine Derivatives Selectively Kill Cancer Cells.